LATEST
Fri, Nov 6, 2026
Loading weather...
Markets

Elutia Inc. Reports Third Quarter 2026 Results and Plans NXT-41x FDA Submission

Elutia Inc. reported its financial results for the third quarter ended September 30, 2026, and provided updates on its p...

Elutia Inc. reported its financial results for the third quarter ended September 30, 2026, and provided updates on its product pipeline. The company announced that it intends to submit NXT-41x, its leading drug delivery program, to the FDA in the fourth quarter of 2026. This plan

SOURCE: Nasdaq
ORIGINAL REPORT: Click here
DHALLO EDITORIAL STATUS: Aggregated & reviewed
Have feedback on this article?Report error or suggestion

Read More from Markets

Why did Yes Bank shares rally 6%, extend winning streak to 3rd day and snap a 7-week losing run — what led to rebound?

Yes Bank shares rose 6% on Friday, extending gains to three sessions and lifting...

Read Article »

Did I Call the Bottom With Rivian Stock?

Should you buy stock in Rivian Automotive right now? Before you buy stock in Riv...

Read Article »

Wynn Resorts, Limited Reports Third Quarter 2026 Results and Declares Cash Dividend of $0.25 Per Share

Wynn Resorts, Limited reported operating revenues of $1.69 billion for the third...

Read Article »
Return to Front Page

5 minutes. The news that matters.

Get the most important stories of the day, without having to browse hundreds of articles.